Q1 2023 D&O Market Outlook
Similarly to the conditions we’re seeing in the E&O market, there is…
...CCIG provides Life Sciences companies at all stages of their development — from the initial discovery phase to final product launch. Our end-to-end solutions can help you address all kinds of risks, including clinical trial failures, product liability, shareholder lawsuits and personal data breaches.
Whether you’re a drug manufacturer, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO) or a publicly traded company, CCIG has an experienced and dedicated team to help manage your risks around the world.
Common life sciences risks covered:
Similarly to the conditions we’re seeing in the E&O market, there is…
...Cyber/E&O premiums are starting to level off. While Cyber remains a challenge…
...OSHA was largely grounded during the first two years of the COVID-19…
...